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Experimental IRMPD spectrum of cis- and trans-[PtCl(NH3)2(H2O)]+ compared to calculated IR spectra
according to MP2 anharmonic and harmonic frequency computations [De Petris A., Ciavardini A., Coletti C., Re N., Chiavarino
B., Crestoni M. E. and Fornarini S., J. Phys. Chem. Lett. 2013, 4, 3631-3635].
ESI-FTICR mass spectra of the two sampled ions obtained in the mass range of m/z 240-290. The platinum
dimer (m/z 245, Pt2(NH3)4(OH)22+) is not observed in the spectrum of the trans isomer.
Optimized Geometries computed at  the 
MP2/6-311G(d,p) level of theory. 
Cisplatin (cis-diamminedichloroplatinum(II) is the first platinum-based antitumor agent, and it is still widely used
in chemotherapy. In the cytoplasm, the administered drug undergoes spontaneous hydrolysis by nucleophilic
substitution of chloride with water. The cationic chloro-monoaqua form, cis-[PtCl(NH3)2(H2O)]+, characterized by
a pKa value of 6.5, is the relevant intermediate at physiological pH, that can ultimately give rise to DNA and
protein adducts through easy substitution of water by nitrogen/sulfur donor ligands.
Electrospray ionization has allowed cis- and trans-[PtCl(NH3)2(H2O)]+ species to be obtained as free ions in the
gas phase where they were sampled by infrared multiple photon dissociation (IRMPD) spectroscopy in the
NH/OH stretching frequency range (3200−3800 cm−1), using a tabletop optical parametric oscillator/amplifier



















Moreover, an accurate characterization of cis-[Pt(NH3)2(Guanine)Cl]+ and cis-[Pt(NH3)2(Adenine)Cl]+, models
of the monofunctional adducts between cisplatin and the nucleobases of DNA, has been gathered using IR
spectroscopy in two spectral regions, 950−1900 and 2900−3700 cm−1, using two different IR radiation sources,
the free electron laser (FEL) at the Centre Laser Infrarouge d’Orsay (CLIO) facility and an optical parametric
oscillator/amplifier (OPO/OPA) laser system @Università Sapienza, Roma (ITALY) respectively.
The cisplatin residue is attached to the N7, N3, or carbonyl oxygen atom, (O6), of guanine and to the N7, N3, or
N1 position of adenine, respectively. The IRMPD spectra of cis-[Pt(NH3)2(A)Cl]+ are consistent with the
presence of two major isomers, PtAN3 and PtAN1, where Pt is bound to the N3 and N1 positions of native
adenine, respectively.
Work is currently underway to characterize the cisplatin derived complexes with the sulfur-containing
molecules, which serve as a drug reservoir available for platination of DNA in the nucleus of tumor cells. The
interaction of cisplatin with biological thiols, including L-methionine, glutathione and cysteine/thiotheneine, has
been associated to resistance, and drug detoxification.
L-methionine and cisplatin may form various monodentate adducts, depending on the site of Pt(II) coordination,
either at N or S atom. An extensive conformational search for low-energy candidate structures has been
performed, followed by ab initio calculations at the B3LYP/6-311+G(d,p) level of theory.
The preferred platinum coordination
site on adenine seems to be N3, which
is not observed in the cell because
such a site is located in the internal
groove and not easily accessible at an
intrastrand cross-linking. In
agreement with computational results,
computed at the B3LYP/LACV3P/6-
311G** level of theory, the IR
characterization of cis-[Pt(NH3)2(G)Cl]+
points to a covalent structure where
Pt is bound to the N7 atom of guanine,
with a hydrogen-bonding interaction
between a hydrogen atom of one NH3
ligand and the carbonyl oxygen of
guanine [Chiavarino B., Crestoni M. E., Fornarini
S., Scuderi D. and Salpin J. Y., J. Am. Chem. Soc.
2013, 135, 1445-1455].














































Crystal structures of DNA complexed with 
intrastrand cisplatin-1,2-cross-linked 
(PDB: 4DL5)
Hydrolysis of cisplatin and transplatin
Reaction of cisplatin with L-Methionine
c) c-S Conf II
b) c-S Conf I
c) c-S Conf II
(11.7 kJ mol-1)
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